March 25th
|
Overview:
Join Outcome Capital at the Medical Development Group of Boston and Hamilton Brook Smith Reynolds for an engaging and insightful event on the transformative impact of 3D printing in the medical device industry. |
In this conversation, Stan Glazer, Managing Director at Outcome, shares insights from his extensive experience in the life sciences industry.
Read MoreOutcome Capital Life Science Market Pulse April 2025 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?